Study of tumor tissue to understand treatment resistance in head and neck cancer
Part of Cancer clinical trials.
This study looks at tumor samples from people with head and neck cancer to understand why some treatments stop working. By studying the tumor tissue, researchers hope to find better ways to treat this cancer in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a diagnosis of squamous cell carcinoma of the head and neck.
- If you are joining after your treatment, you must have been treated with cetuximab in the last 10 years.
- If you are joining now, you will be one of the patients recruited over the next 5 years.
- You will need to provide written consent to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tissue samples from patients who had surgery for head and neck or breast cancer. Researchers want to understand how certain immune cells in the tumor might affect the cancer, which could help improve treatments in the future.
This study looks at why some head and neck cancers come back after treatment. It will test tumor tissue from people having surgery to see if certain proteins (mutant p53 and YAP) are linked to treatment resistance. Your participation could help researchers understand how to better treat these cancers in the future.
This trial studies the role of epigenetic marks in head and neck cancer to improve diagnosis and treatment. If you have been newly diagnosed with head and neck squamous cell carcinoma and have not yet received treatment, you may be eligible to participate.
This study compares gene patterns in tumor tissue and blood samples from patients with HPV-negative head and neck cancer. Understanding these patterns may help doctors better understand the disease and develop better treatments.
This study uses tumor tissue taken from people with head and neck cancer, then grows it in a lab to better understand the cancer and predict responses. If you have a new or returning cancer and can share key medical details and follow-up information, you may be able to take part.
This study collects blood and tumor tissue samples to analyze biological markers in patients with advanced head and neck squamous cell carcinoma before starting immunotherapy. The goal is to better understand how these markers relate to treatment response.
Hear when a new Squamous Cell Tumors of the Head and Neck (HNSCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.